UNSPSC 51161730: Fenspiride hydrochloride

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H20N2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 832NBX878V, chemically known as 8-phenethyl-1-oxa-3,8-diazaspiro(4.5)decan-2-one monohydrochloride but more generally known as fenspiride hydrochloride, which bears US NIH Compound Identifier 68626. European Medicines Agency schedules Fenspiride hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02128MIG.

UNSPSC 51161730 Fenspiride hydrochloride is a Commodity code that nominally covers a specific pharmaceutical active ingredient, but the recent state and local opportunities tagged under it show little alignment with that narrow scope. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a two-year initial term with one-year renewal option. Hall County, Georgia issued RFQ/P #47-010 in May 2026 to solicit on-site pharmacy services at its Family Health Center Clinic, covering approximately 3,005 eligible individuals across multiple health insurance plans and requiring vendors to stock and dispense a formulary of 25 medications across multiple therapeutic categories, with contract term beginning January 1, 2027, and four one-year renewal options available. Both opportunities are routed through county health and human services functions rather than procurement of fenspiride specifically, suggesting the code may be incorrectly tagged or represents pharmaceutical procurement more broadly than its nominal name indicates.

The recent activity spans Florida and Georgia, with both county-level health systems as issuing bodies. Neither opportunity specifies set-aside designations for disadvantaged enterprises. Seminole County's naloxone procurement carries potential FEMA funding with associated compliance requirements, while Hall County's pharmacy RFQ employs an 80/20 technical-to-cost evaluation structure with 80 scored questions and requires comprehensive insurance coverage including cyber liability. Response deadlines have passed for both opportunities (July 26, 2023, for Seminole County and June 4, 2026, for Hall County). The code shows limited recent relevant activity; prospective vendors should verify whether this commodity designation accurately reflects their service scope or whether alternative pharmaceutical-supply or pharmacy-services codes better align with their offerings.